| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Departments of Medicine and Pharmacology, Medical College of Ohio, Toledo, Ohio.
Correspondence to Dr. Joseph I. Shapiro, Chairman, Department of Medicine, Medical College of Ohio, 3120 Glendale Avenue, Toledo, Ohio 43614-5089. Phone: 419-383-6030; Fax: 419-383-6244;
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
For many years, it has been known that the sodium pump is abnormal in chronic renal failure and that circulating inhibitor(s) can be demonstrated in the serum of uremic patients (46). We have observed that sodium pump inhibition initiates a signal cascade that can cause alterations in gene transcription and ultimately produce hypertrophy in cardiomyocytes grown in culture (79). We have also observed that sodium pump inhibitors, including those circulating in the serum of uremic patients, can acutely cause altered calcium cycling and cardiomyocyte relaxation through sodium pump inhibition (10). The following studies were performed to further examine how cardiac growth and function are chronically modified by the uremic milieu.
| Materials and Methods |
|---|
|
|
|---|
Isolation and Culture of Cardiac Myocytes
Details of the method of isolation and culture of calcium-tolerant adult myocytes may be found in several recent reports from our laboratory (9,10,12). This method of isolation produced a good yield of rod-shaped (70 to 80%) myocytes in each of the experimental groups presented here.
Measurements of the Calcium Transient and Contractility
The calcium transient was measured by using the calcium-selective fluorescent dye indo-1 and spectrofluorometer (Photon Technology International, Monmouth Junction, NJ). Myocyte contractility was measured simultaneously using an edge detector system (Crystal Biotech, Northboro, MA), which, along with the spectrofluorometer, was interfaced with an inverted microscope. The simultaneous observation of both indo-1 fluorescence and edge detection was accomplished by continuous illumination of the cells during field stimulation with a red light and splitting of the emission light based on wavelength to either a video imaging system or the spectrofluorometer. Again, details of this methodology may be found in recent reports from our laboratory (9,10,12). Calculations of cytosolic calcium concentration ([Ca2+]I) were made using the following formula:
|
| (1) |
where the Kd was assumed to be 250 nM, the Dfree and Dbound represent the intensity of the fluorescence at 485 nm after EGTA (4 mM) and Ionomycin (10-6 M) treatment of the cell, respectively, and Rmin and Rmax were the ratios obtained under these conditions.
The time constant,
, for recovery of length and calcium after electrical stimulation was performed by fitting a least square regression line to the log transformation of the edge detection and fluorescence data, respectively, as described by Bers et al. (13,14) and also reported previously by our group (10).
StaRT PCR
Analysis of gene expression for proteins important in calcium homeostasis as well as markers of cardiac hypertrophy was performed using standardized reverse transcription PCR (StaRT-PCR), which allows for quantitative measurement of gene expression on the basis of the ratio of native PCR products to specific competitive templates (CT) (15). Detailed description of the principles, reagents, and protocol for this methodology may be found in several recent reports (1518). Briefly, left ventricles obtained from remnant and sham-treated rats were homogenized, and total RNA extraction was performed on the tissue homogenate as described by the TRI-REAGENT protocol (Molecular Research Center, Inc, Cincinnati, OH). Reverse transcription (RT) (5 min denaturing at 94°C, 1 h incubation at 37 (10), 5 min heat stopped at 94°C) and PCR was then performed.
Primers for all target and housekeeping genes that were evaluated in this study are listed in Table 1. Reaction volumes were 10 µl and each contained 0.05 µg of each primer, 0.5 U Taq polymerase, 1 µl PCR buffer, 0.2 mM dNTPs, 1 µl of a CT mixture containing the desired molarity of each CT, and 1 µl cDNA diluted such that native GAPDH competed equally with the GAPDH CT present in the chosen CT mixture. The PCR reaction mixtures were placed in capillary tubes and cycled 35 times in a Rapidcycler air thermocycler (Idaho Technology). Each cycle consisted of 5 s at 94°C, 10 s at 58°C, and 15 s at 72°C, with a slope of 9.9, for a total amplification time of approximately 25 min. The PCR products were electrophoresed on either DNA 7500 or 1000 assay LabChips (Agilent Technologies, Palo Alto, CA), and quantitative analysis was performed as described previously (15). Levels of expression are reported as units of messenger RNA (mRNA)/106 copies of GAPDH.
|
-mercaptoethanol, 20% glycerol, 0.005% bromophenol blue, and 50 mM Tris-HCl, pH 7.0, the proteins in the homogenates were resolved as described by Laemmli (20 on a SDS-PAGE using 10% gel. The proteins were transferred to nitrocellulose membrane following the method of Towbin et al. (21) and immunoblotted with anti-SERCA2 mAb or anti-NCX-1 mAb (Affinity Bioreagents, Inc., Golden, CO). The immunoreactive products were visualized with horseradish peroxide conjugated to donkey anti-mouse IgG (Affinity Bioreagents, Inc.) using an enhanced chemiluminescence substrate (Pierce, Rockford, IL). The images of the immunoreactive products were quantified with a Molecular Analyst software program (BioRad Laboratories, Hercules, CA).
Measurement of Na+/K+-ATPase Activity
Cardiac homogenates were prepared in the presence of protease inhibitors, and ouabain-sensitive Na+/K+-ATPase activity was measured as we have previously reported (7).
Measurement of SERCA2a Activity
To measure sarcoplasmic reticulum calcium ATPase activity (which we are assuming is predominantly SERCA2a activity [22,23]), the method of Simonides and Hardeveld (24) was used with modifications. Homogenates of left ventricles of rats were prepared in a medium containing 25 mM imidazole (pH 7.0) and protease inhibitors. Homogenates were then subjected to freeze-thaw cycles five times to open up the vesicles formed during the homogenization. The assay medium consists of 1.0 ml containing 40 mM imidazole (pH 7.0), 100 mM KCl, 5 mM K+ oxalate, 5 mM NaN3, 3 mM MgCl2, 2 mM ouabain, 200 to 220 µg of homogenate, 3 mM (
-32P)-ATP, and 10 µM CaCl2 or 2 mM EGTA. After a 5 min preincubation at 37°C, enzymatic reaction was initiated by the addition of (
-32P)-ATP and terminated 15 min later by the addition of 8% perchloric acid. Released inorganic (32P)-phosphate was measured as described by Askari et al. (25). The difference between ATPase activity in the presence and absence of CaCl2 was considered as SERCA2a activity.
Statistical Analyses
Data obtained were first tested for normality. If the data did not pass the normality test, the Tukey test (for multiple groups) or the Mann-Whitney rank sum test were used to compare the data. If the data did pass the normality test, parametric comparisons were performed. If more than two groups were compared, one-way ANOVA was performed before comparison of individual groups with the unpaired t test with Bonferroni correction for multiple comparisons. If only two groups of normal data were compared, the t test was used without correction (26). Statistical analyses were performed using Sigmastat software. All animal experimentation described in the manuscript was conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals using protocols approved by the Medical College of Ohio Institutional Animal Use and Care (IACUC) Committee.
| Results |
|---|
|
|
|---|
|
1 and
2 isoforms, whereas the decrease in Na+/K+ ATPase appeared to be confined to the
2 isoform in the aortic constriction rat hearts (Figure 1).
|
values for both calcium and length recovery after stimulation (Table 3).
|
|
2 isoform of Na+/K+-ATPase as well as increases in skACT and ANP (Table 4). In particular, SERCA2a message was reduced by 50% (P < 0.01) in these 5/6 nephrectomy hearts.
|
| Discussion |
|---|
|
|
|---|
We observed that chronic renal failure induced by partial (5/6) nephrectomy was associated with marked increases in cardiac size, a phenomenon that could not be accounted for only by the hypertension associated with this model. We also noted characteristic changes in message expression quite similar to that seen in ouabain-induced cardiac hypertrophy in vitro. Specifically, we saw increases in the transcription of ANP and skACT, which appears to accompany all pressure overload type cardiac hypertrophy (31) as well as decreases in the
2 isoform of Na+/K+ ATPase. The fall in
2 expression is analogous to the decrease in
3 expression in neonatal cardiac myocyte hypertrophy induced with ouabain (32,33) or observed with the coincident exposure to both pressure overload and potassium depletion together (7) or pressure overload alone (34). We have postulated that the decrease in
2 (or
3) expression may constitute a negative feedback attenuating hypertrophy induced by ouabain or other digitalis-like substances (9,32,33). In the remnant kidney cardiac cells, we noted that in addition to the decreases in
2 Na+/K+-ATPase, the
1 isoform protein expression was also significantly decreased. We did not examine
3 isoform expression in the current study.
We must point out that the hematocrit was diminished in the chronic renal failure rats, raising the possibility that the accelerated hypertrophy in these animals was due to an additive or synergistic effect between pressure and volume overload as suggested to occur in patients with chronic renal failure (35). Although our gene expression data appear more consistent with a purely "pressure overload" phenotype (34), it is not possible to exclude this possibility from our data.
Our findings regarding sodium pump gene expression are submitted on a literature background, which is plagued by inconsistency, at least in the case of chronic renal failure. Greiber et al. (36) reported essentially no difference in
1 and
2 isoform mRNA or protein expression in a similar model of chronic renal failure studied at approximately the same time point. Da Silva et al. (37) found significant decreases in cardiac mRNA for
2 without any changes in
2 protein observed. Bonilla et al. (38) reported decreases in both Na+/K+ ATPase activity as well as mRNA for the
1 isoform in skeletal muscle; however, these workers found an increase in
2 mRNA in this tissue. At present, the reason(s) for the discrepancy between our findings and these other studies is/are not clear.
Regarding the myocyte function, we found that the cells isolated from the hearts of rats bearing remnant kidney demonstrated both systolic and diastolic dysfunction in vitro. Our findings were quite similar to that reported by McMahon et al. in 1996 (39). This was in contrast to the heart cells isolated from the aortic clip rats, which demonstrated grossly normal function and calcium cycling at the time of isolation, which was between 4 to 6 wk after surgery; this observation was also consistent with previous studies performed early after induction of aortic banding (40). The systolic dysfunction seen in the heart cells from the remnant kidney rats was strikingly similar to that observed when heart cells are isolated from rats with congestive heart failure from a variety of causes, including aortic constriction (41). We particularly noted marked calcium insensitivity in these heart cells with the diastolic calcium value substantially elevated compared with sham-treated rats. It appears that it takes considerably longer periods of aortic constriction to produce abnormal systolic function and calcium insensitivity in these isolated myocytes than the induction of uremia by the 5/6 nephrectomy model that is associated with very similar BP elevation in the species and strain that we employed (42). Although most patients with chronic renal failure display normal (or even supranormal) systolic function (2), we suggest that the digitalis-like substances that circulate in such patients might mask underlying contractile problems (10).
Other investigators have also noted increases in cytosolic calcium during experimental uremia, but this has been ascribed to the associated secondary hyperparathyroidism (43). Although we did not attempt to dissect out the role of parathyroid hormone in this current study, we have previously reported that acute sodium pump inhibition by deproteinated serum extract as well as administration of cardiac glycosides elevates cardiac cytosolic calcium (7,9,10). We speculate that chronic exposure to such sodium pump inhibition could alter cardiac calcium cycling, contractile function, and gene expression on a chronic basis. However, this speculation as well as the role that parathyroid hormone plays in the regulation of circulating inhibitors of the sodium pump requires additional study.
In addition to this systolic dysfunction, we also observed substantial diastolic dysfunction characterized by delayed recovery of length in parallel with a longer time constant (
) describing calcium recovery after stimulation (44). This has also been observed in a variety of cardiomyopathies, including that induced by prolonged (> 12 wk) aortic banding (45). Although the decrease in cytosolic calcium after stimulation depends on several processes, the most quantitatively important are through reuptake of calcium into the sarcoplasmic reticulum and extrusion out of the cell via the sodium calcium exchanger. Bassani et al. (46) reported that sarcoplasmic reticulum calcium reuptake is the major determinant of the rate of decay of the calcium transient in rat cells with the sodium calcium exchanger accounting for substantially less of this calcium recovery in the rat. Although the sodium calcium exchanger is responsible for the majority of calcium efflux in myocytes, it can also serve as a calcium influx mechanism (47).
Experimental and human heart failure are typically characterized by a decrease in SERCA2a (48,49) and an increase in NCX-1 (50), although it should be noted that some studies have observed NCX-1 to be unchanged or even decreased (51,52). Thus, some authors suggest that the [Ca2+]I is determined by the interactions between these two calcium handling proteins taken together (i.e., the ratio of NCX-1 to SERCA) rather than either one separately (53). Thus, to elucidate the mechanisms responsible for deranged calcium metabolism seen with 5/6 nephrectomy, we focused our investigation on SERCA2a and NCX-1, as these proteins represent the predominant cardiac isoforms of both the sarcoplasmic reticulum calcium ATPase and the sodium calcium exchanger, respectively. In our setting, we have decreased levels of SERCA2a and increased levels of NCX-1. It has been suggested that in pathophysiologic conditions where there is a reduction in SERCA2a function, overexpression of NCX-1 may participate in a compensatory attempt to maintain normal calcium homeostasis (54). On the basis of our data, it appears that transcriptional downregulation of SERCA2a leads to decreases in sarcoplasmic reticulum calcium reuptake and impaired myocyte relaxation in this model. As discussed above, it is unclear what role parathyroid hormone and circulating digitalis-like substances play in the regulation of these transport proteins in the setting of chronic renal failure, and further examination of this important area is certainly warranted.
In summary, we observed that uremia induced by 5/6 nephrectomy caused marked cardiac hypertrophy and changes in cardiac gene expression that could not be explained by only the observed increases in BP. We also noted that calcium cycling and contractile function were deranged in the myocytes isolated from these hearts and that transcriptional downregulation of the SERCA2a may account for the impaired diastolic function seen in these myocytes.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
L. G. Bongartz, B. Braam, M. C. Verhaar, M. J. Cramer, R. Goldschmeding, C. A. Gaillard, P. A. Doevendans, and J. A. Joles Transient nitric oxide reduction induces permanent cardiac systolic dysfunction and worsens kidney damage in rats with chronic kidney disease Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2010; 298(3): R815 - R823. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tian, A. Shidyak, S. M. Periyasamy, S. Haller, M. Taleb, N. El-Okdi, J. Elkareh, S. Gupta, S. Gohara, O. V. Fedorova, et al. Spironolactone Attenuates Experimental Uremic Cardiomyopathy by Antagonizing Marinobufagenin Hypertension, December 1, 2009; 54(6): 1313 - 1320. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kuncova, J. Sviglerova, W. Kummer, D. Rajdl, M. Chottova-Dvorakova, Z. Tonar, L. Nalos, and M. Stengl Parasympathetic regulation of heart rate in rats after 5/6 nephrectomy is impaired despite functionally intact cardiac vagal innervation Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2362 - 2370. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Elkareh, S. M. Periyasamy, A. Shidyak, S. Vetteth, J. Schroeder, V. Raju, I. M. Hariri, N. El-Okdi, S. Gupta, L. Fedorova, et al. Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy Am J Physiol Renal Physiol, May 1, 2009; 296(5): F1219 - F1226. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Bagrov, J. I. Shapiro, and O. V. Fedorova Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets Pharmacol. Rev., March 1, 2009; 61(1): 9 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Schoner and G. Scheiner-Bobis Role of endogenous cardiotonic steroids in sodium homeostasis Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2723 - 2729. [Full Text] [PDF] |
||||
![]() |
A. M. de Mattos, A. Siedlecki, R. S. Gaston, G. J. Perry, B. A. Julian, C. E. Kew II, M. H. Deierhoi, C. Young, J. J. Curtis, and A. E. Iskandrian Systolic Dysfunction Portends Increased Mortality among Those Waiting for Renal Transplant J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1191 - 1196. [Full Text] [PDF] |
||||
![]() |
L. Burchill, E. Velkoska, R. G. Dean, R. A. Lew, A. I. Smith, V. Levidiotis, and L. M. Burrell Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression Exp Physiol, May 1, 2008; 93(5): 622 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Kennedy, J. Elkareh, A. Shidyak, A. P. Shapiro, S. Smaili, K. Mutgi, S. Gupta, J. Tian, E. Morgan, S. Khouri, et al. Partial nephrectomy as a model for uremic cardiomyopathy in the mouse Am J Physiol Renal Physiol, February 1, 2008; 294(2): F450 - F454. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Elkareh, D. J. Kennedy, B. Yashaswi, S. Vetteth, A. Shidyak, E. G. R. Kim, S. Smaili, S. M. Periyasamy, I. M. Hariri, L. Fedorova, et al. Marinobufagenin Stimulates Fibroblast Collagen Production and Causes Fibrosis in Experimental Uremic Cardiomyopathy Hypertension, January 1, 2007; 49(1): 215 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Kennedy, S. Vetteth, M. Xie, S. M. Periyasamy, Z. Xie, C. Han, V. Basrur, K. Mutgi, V. Fedorov, D. Malhotra, et al. Ouabain decreases sarco(endo)plasmic reticulum calcium ATPase activity in rat hearts by a process involving protein oxidation Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H3003 - H3011. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kennedy, S Vetteth, S. Periyasamy, M Kanj, L Fedorova, S Khouri, M. Kahaleh, Z Xie, D Malhotra, N. Kolodkin, et al. Uremic Cardiomyopathy--An Endogenous Digitalis Intoxication?: Central Role for the Cardiotonic Steroid Marinobufagenin in the Pathogenesis of Experimental Uremic Cardiomyopathy. Hypertension 47: 488-495, 2006 J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1493 - 1497. [Full Text] [PDF] |
||||
![]() |
P. Ochodnicky, D. de Zeeuw, R. H. Henning, C. A. Kluppel, and R. P.E. van Dokkum Endothelial Function Predicts the Development of Renal Damage after Combined Nephrectomy and Myocardial Infarction J. Am. Soc. Nephrol., April 1, 2006; 17(4_suppl_2): S49 - S52. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Kennedy, S. Vetteth, S. M. Periyasamy, M. Kanj, L. Fedorova, S. Khouri, M. B. Kahaleh, Z. Xie, D. Malhotra, N. I. Kolodkin, et al. Central Role for the Cardiotonic Steroid Marinobufagenin in the Pathogenesis of Experimental Uremic Cardiomyopathy Hypertension, March 1, 2006; 47(3): 488 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Barbato, S. Rashid, P. J. Mulrow, J. I. Shapiro, and R. Franco-Saenz Mechanisms for Aldosterone and Spironolactone-Induced Positive Inotropic Actions in the Rat Heart Hypertension, November 1, 2004; 44(5): 751 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dikow, L. P. Kihm, M. Zeier, J. Kapitza, J. Tornig, K. Amann, C. Tiefenbacher, and E. Ritz Increased Infarct Size in Uremic Rats: Reduced Ischemia Tolerance? J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1530 - 1536. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zoccali, F. A. Benedetto, F. Mallamaci, G. Tripepi, G. Giacone, A. Cataliotti, G. Seminara, B. Stancanelli, and L. S. Malatino Prognostic Value of Echocardiographic Indicators of Left Ventricular Systolic Function in Asymptomatic Dialysis Patients J. Am. Soc. Nephrol., April 1, 2004; 15(4): 1029 - 1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu and J. I. Shapiro Endocytosis and Signal Transduction: Basic Science Update Biol Res Nurs, October 1, 2003; 5(2): 117 - 128. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |